Author(s): Mukthinuthalapati Mathrusri Annapurna, Palyam Bhanu, Kandula Venkat Navya

Email(s): mannapurna.mukthinuthalapati@gitam.edu

DOI: 10.5958/0974-360X.2019.00835.7   

Address: Mukthinuthalapati Mathrusri Annapurna*, Palyam Bhanu, Kandula Venkat Navya
Department of Pharmaceutical Analysis & Quality Assurance, Gandhi Institute of Technology and Management, GITAM Institute of Pharmacy, GITAM (Deemed to be University), Visakhapatnam, Andhra Pradesh-530045, India.
*Corresponding Author

Published In:   Volume - 12,      Issue - 10,     Year - 2019


ABSTRACT:
Glibenclamide is an anti-diabetic agent used for the treatment of diabetes mellitus type 2. First derivative spectrophotometric techniques were developed for the assay of Glibenclamide tablet dosage forms in three different reagents and the methods were validated. Glibenclamide has shown linearity over the concentration range 1-80, 1-100 and 1-80 µg/ml respectively in phosphate buffer pH 2.0 (Method A), phosphate buffer pH 8.0 (Method B) and borate buffer pH 9.0 (Method C) respectively. The methods were validated by precision and accuracy studies and are suitable for the determining the assay of Glibenclamide tablets.


Cite this article:
Mukthinuthalapati Mathrusri Annapurna, Palyam Bhanu, Kandula Venkat Navya. Derivative spectrophotometric methods for the assay of Glibenclamide (An anti-diabetic agent). Research J. Pharm. and Tech 2019; 12(10):4827-4830. doi: 10.5958/0974-360X.2019.00835.7

Cite(Electronic):
Mukthinuthalapati Mathrusri Annapurna, Palyam Bhanu, Kandula Venkat Navya. Derivative spectrophotometric methods for the assay of Glibenclamide (An anti-diabetic agent). Research J. Pharm. and Tech 2019; 12(10):4827-4830. doi: 10.5958/0974-360X.2019.00835.7   Available on: https://rjptonline.org/AbstractView.aspx?PID=2019-12-10-45


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available